A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

NCT05934942 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Healthy

Interventions

DRUG: Yasmin®
DRUG: BI 1358894

Sponsor

Boehringer Ingelheim